Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 26 Aug 2024 for Agile Therapeutics INC, €1,325. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Sharon Barbari: trading record in brief
Sharon Barbari, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Agile Therapeutics Inc and Yarrow Bioscience, Inc. We count 6 filings; the first trade dates from 9 June 2020 and the latest from 26 August 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 26 August 2024: a transaction of €1,325, in Agile Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sharon Barbari
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
973 shares@ US$1.52100.0% of flowCommon StockSEC:0001104659-24-092940:0
935 shares0Common StockSEC:0000929638-23-001706:0
670 shares0Common StockSEC:0001104659-22-070184:0
24,510 shares0Common StockSEC:0001104659-21-079619:0
4 of 4 declarations
